HighTower Advisors’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,311
Closed -$6K 3897
2023
Q4
$6K Buy
10,311
+11
+0.1% +$4 ﹤0.01% 3466
2023
Q3
$4K Hold
10,300
﹤0.01% 3435
2023
Q2
$5K Hold
10,300
﹤0.01% 3341
2023
Q1
$9K Buy
+10,300
New +$11.2K ﹤0.01% 3199
2021
Q4
Sell
-23,025
Closed -$163K 3417
2021
Q3
$163K Buy
+23,025
New +$169K ﹤0.01% 2760

Other funds holding OCGN

HighTower Advisors's OCGN Position: Q1 2024 in Review

HighTower Advisors sold out of Ocugen (OCGN) in Q1 2024, closing a stake of 10,311 shares — an estimated $6K sold.

HighTower Advisors first reported a position in OCGN in Q3 2021 and held it in 5 quarters. The position peaked at $163K in Q3 2021. 81 funds tracked by Wall St. Rank hold OCGN as of Q1 2024.

  • HighTower Advisors reported no remaining Ocugen position as of Q1 2024 after selling out during the quarter.
  • HighTower Advisors sold 10,311 Ocugen shares in Q1 2024, an estimated $6K.
  • HighTower Advisors first reported a position in Ocugen in Q3 2021 and held it in 5 quarters.
  • HighTower Advisors's Ocugen position peaked at $163K in Q3 2021.
  • 81 funds tracked by Wall St. Rank held Ocugen as of Q1 2024.

Based on HighTower Advisors's 13F filing for Q1 2024, filed 6 May 2024.